Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.96
0.16 (1.08%)
At close: Aug 15, 2025, 11:58 AM
Takeda Pharmaceutical Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | 107.88B | 208.06B | 290.03B | 150.01B | 144.17B | 178.33B | 191.72B | 301.42B | 317.04B | 274.53B | 213.2B | 197.46B | 230.17B | 438.69B | 473.3B | 431.38B |
Depreciation & Amortization | 761.4B | 758.37B | 758.48B | 748.72B | 728B | 702.67B | 692.49B | 677.62B | 664.4B | 655.26B | 625.67B | 598.49B | 583.15B | 570.27B | 562.74B | 561.03B |
Stock-Based Compensation | 51.31B | 51.87B | 52.28B | 70.81B | 70.87B | 67.53B | 65.31B | 63.82B | 60.67B | 57.14B | 51.74B | 47.12B | 43.37B | 41.6B | 40.54B | 36.17B |
Other Working Capital | -77.75B | -46.24B | -281.48B | -203.16B | -131.04B | -114.07B | 150.66B | 105.24B | 107.72B | 59.86B | -56.37B | -33.09B | -78.21B | 147.74B | 224.61B | 237.4B |
Other Non-Cash Items | 807.56B | 989.15B | 949.02B | 986.13B | 365.89B | -14.99B | -34.03B | -123.03B | -97.74B | 63.49B | 82.42B | 88.78B | 95.4B | -128.67B | -216.91B | -190.26B |
Deferred Income Tax | 41.3B | -3.22B | -47.72B | -95.73B | -91.41B | -30.1B | 2.4B | 53.23B | 58.05B | -1.4B | 24.97B | 37.6B | 72.41B | 48.81B | 51.8B | 27.54B |
Change in Working Capital | -208.76B | -102.24B | -337.39B | -255.35B | -216.32B | -171.99B | 45.34B | 12.26B | -25.26B | 10.03B | 30.33B | 71.04B | 98.61B | 177.79B | 107.47B | 166.07B |
Operating Cash Flow | 1,024.3B | 1,074.6B | 837.3B | 777.21B | 710.23B | 731.45B | 963.23B | 985.32B | 977.16B | 1,059B | 1,028.3B | 1,040.5B | 1,123.1B | 1,148.5B | 1,018.9B | 1,031.9B |
Capital Expenditures | -281.15B | -296.69B | -328.72B | -349.29B | -480.73B | -860.48B | -833.98B | -804.55B | -633.69B | -241.43B | -239.24B | -242.12B | -186.04B | -246.17B | -241.36B | -238.28B |
Cash Acquisitions | 8.37B | -5.34B | -31.59B | -37.01B | -39.59B | -17.93B | -6.7B | -14.68B | -70.66B | -52.56B | -59.66B | -62.31B | -32.11B | 347.25B | 462.94B | 504.98B |
Purchase of Investments | -23.03B | -25.07B | -27.53B | -19.07B | -6.77B | -9.43B | -7.72B | -7.89B | -10.15B | -6.18B | -9.44B | -8.02B | -8.34B | -10.72B | -9.97B | -12.33B |
Sales Maturities Of Investments | 23.11B | 30.05B | 30.5B | 12.79B | 8.02B | 2.79B | 4.49B | 16.62B | 22.25B | 21.41B | 25.25B | 22.62B | 16.92B | 16.95B | 34.02B | 30.65B |
Other Investing Acitivies | -92.57B | -125.6B | -25.03B | 18.44B | 39.63B | 44.19B | 31.63B | 31.58B | 85.14B | 84.51B | 45.04B | 22.72B | -33.28B | -31.19B | -7.04B | 37.41B |
Investing Cash Flow | -376.46B | -433.84B | -393.56B | -374.14B | -479.44B | -840.87B | -812.29B | -778.92B | -607.1B | -194.25B | -216.7B | -222.39B | -198.13B | 120.84B | 261.96B | 322.42B |
Debt Repayment | -635.43B | -98.71B | 275.66B | 175.68B | -165.49B | -125.19B | -294.88B | -148.58B | -285.07B | -498.95B | -186.76B | -384.36B | -600.48B | -742.27B | -923.66B | -906.18B |
Common Stock Repurchased | -51.86B | -1.88B | -1.88B | -1.88B | -2.33B | -2.33B | -2.33B | -2.33B | -26.93B | -51.92B | -101.92B | -101.92B | -77.53B | -52.54B | -2.55B | -2.55B |
Dividend Paid | -302.5B | -301.89B | -294.69B | -294.55B | -287.19B | -288.48B | -279.22B | -281.29B | -279.42B | -279.64B | -282.1B | -280.51B | -283.67B | -281.7B | -283.18B | -282.27B |
Other Financial Acitivies | 280.66B | -63.08B | 113.56B | 155.97B | 100.58B | 113.2B | -63.56B | -119.02B | -117.73B | -115.83B | -108.67B | -108.16B | -108.59B | -120.03B | -119.16B | -115.62B |
Financial Cash Flow | -709.13B | -443.87B | 114.34B | 56.9B | -332.73B | -302.79B | -639.99B | -551.21B | -709.15B | -946.35B | -679.45B | -874.94B | -1,070.3B | -1,196.5B | -1,328.5B | -1,306.6B |
Net Cash Flow | 179.92B | 458.38B | 793.57B | 740.5B | -75.73B | -396.78B | -480.09B | -329.61B | -316.17B | -39.2B | 190.26B | -8.93B | -116.53B | 106.71B | -22.99B | 65.13B |
Free Cash Flow | 743.14B | 777.92B | 508.58B | 427.91B | 229.5B | -129.03B | 129.24B | 180.76B | 343.47B | 817.62B | 789.09B | 798.37B | 937.07B | 902.31B | 777.57B | 793.64B |